Piper Sandler Expands European Healthcare Investment Banking with the Hiring of Richard Singh
Piper Sandler Companies (NYSE: PIPR) has appointed Richard Singh as a managing director in its healthcare investment banking group, based in London. Singh previously led healthcare advisory efforts at Gleacher Shacklock LLP and held a managing director role at Citigroup. His addition aligns with Piper Sandler's strategy to enhance its healthcare investment banking operations in Europe. Singh joins Vincenzo di Nicola to expand global outsourcing pharma coverage, aiming to deliver growth opportunities and maximize shareholder value.
- Richard Singh's extensive experience brings added value to Piper Sandler's healthcare investment banking group.
- Strategic expansion in Europe reflects Piper Sandler's commitment to growth in healthcare services.
- None.
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Richard Singh as a managing director within the healthcare investment banking group. He will be based in the firm’s London office.
Prior to joining Piper Sandler, Singh was a partner at the independent advisory firm Gleacher Shacklock LLP, where he was responsible for leading the firm’s healthcare advisory efforts. Prior to that, he was a managing director focused on healthcare services and life sciences at Citigroup. Earlier in his career, Singh also worked at Dresdner Kleinwort Wasserstein and Lehman Brothers. Singh holds a master’s degree in social and political science from Trinity Hall, Cambridge, he was called to the Bar at The Honourable Society of Gray’s Inn and also holds a Master of Business Administration from the International Institute for Management Development in Lausanne, Switzerland.
“We are thrilled to welcome Richard to the team and to continue the expansion of our healthcare investment banking footprint in Europe,” said Peter Day, global co-head of healthcare investment banking at Piper Sandler. “With two decades of investment banking experience, Richard brings a wealth of experience and relationships which will add tremendous value to our clients and our broader platform.”
Singh’s addition is representative of the firm’s European healthcare investment banking growth strategy. Earlier this year, the firm welcomed Vincenzo di Nicola to the London office to broaden its global outsourcing pharma coverage and European healthcare coverage. Together, Singh and Di Nicola will work alongside Neil Mackison, a London-based legacy Piper Sandler healthcare banker, to accelerate the firm’s growth in Europe. Piper Sandler’s experienced team of industry experts is committed to identifying and delivering strategic growth opportunities, exit solutions and the access to capital to maximize shareholder value.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates.
Follow Piper Sandler: LinkedIn | Facebook | Twitter
©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036
View source version on businesswire.com: https://www.businesswire.com/news/home/20210511005370/en/
FAQ
Who is Richard Singh and what is his role at Piper Sandler (PIPR)?
What is Piper Sandler's strategy in healthcare investment banking in Europe?
What experience does Richard Singh have prior to joining Piper Sandler (PIPR)?
What will Richard Singh and Vincenzo di Nicola focus on at Piper Sandler (PIPR)?
